Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
103,200,142
-
Share change
-
+4,587,681
-
Total reported value
-
$5,889,345,445
-
Put/Call ratio
-
170%
-
Price per share
-
$57.07
-
Number of holders
-
424
-
Value change
-
+$257,969,528
-
Number of buys
-
191
-
Number of sells
-
198
Institutional Holders of BIOVERATIV INC - COM (BIVV) as of Q3 2017
As of 30 Sep 2017,
BIOVERATIV INC - COM (BIVV) was held by
424 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,200,142 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, HealthCor Management, L.P., Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, GOLDMAN SACHS GROUP INC, and WELLS FARGO & COMPANY/MN.
This page lists
425
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.